- Home
- Publications
- Publication Search
- Publication Details
Title
Expression and clinical relevance of MET and ALK in Ewing sarcomas
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF CANCER
Volume 133, Issue 2, Pages 427-436
Publisher
Wiley
Online
2013-01-21
DOI
10.1002/ijc.28047
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Randomized Controlled Trial of Interval-Compressed Chemotherapy for the Treatment of Localized Ewing Sarcoma: A Report From the Children's Oncology Group
- (2012) Richard B. Womer et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic significance of overexpression of c-Met oncoprotein in cholangiocarcinoma
- (2011) M Miyamoto et al. BRITISH JOURNAL OF CANCER
- VEGF and c-Met Blockade Amplify Angiogenesis Inhibition in Pancreatic Islet Cancer
- (2011) W.-K. You et al. CANCER RESEARCH
- Activity of XL184 (Cabozantinib), an Oral Tyrosine Kinase Inhibitor, in Patients With Medullary Thyroid Cancer
- (2011) Razelle Kurzrock et al. JOURNAL OF CLINICAL ONCOLOGY
- METAmplification Identifies a Small and Aggressive Subgroup of Esophagogastric Adenocarcinoma With Evidence of Responsiveness to Crizotinib
- (2011) Jochen K. Lennerz et al. JOURNAL OF CLINICAL ONCOLOGY
- Anaplastic Lymphoma Kinase Aberrations in Rhabdomyosarcoma: Clinical and Prognostic Implications
- (2011) J. Carlijn van Gaal et al. JOURNAL OF CLINICAL ONCOLOGY
- Targets for cancer therapy in childhood sarcomas
- (2010) Marco Wachtel et al. CANCER TREATMENT REVIEWS
- Ewing sarcoma: historical perspectives, current state-of-the-art, and opportunities for targeted therapy in the future
- (2010) Joseph A Ludwig CURRENT OPINION IN ONCOLOGY
- Ewing's sarcoma
- (2010) Naomi J Balamuth et al. LANCET ONCOLOGY
- Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
- (2010) Eunice L. Kwak et al. NEW ENGLAND JOURNAL OF MEDICINE
- Initial testing (stage 1) of the IGF-1 receptor inhibitor BMS-754807 by the pediatric preclinical testing program
- (2010) E. Anders Kolb et al. PEDIATRIC BLOOD & CANCER
- Angiogenesis and vascular targeting in Ewing sarcoma
- (2009) Steven G. DuBois et al. CANCER
- The Insulin-like Growth Factor-1 Receptor-Targeting Antibody, CP-751,871, Suppresses Tumor-Derived VEGF and Synergizes with Rapamycin in Models of Childhood Sarcoma
- (2009) R. T. Kurmasheva et al. CANCER RESEARCH
- Mutation-Independent Anaplastic Lymphoma Kinase Overexpression in Poor Prognosis Neuroblastoma Patients
- (2009) L. Passoni et al. CANCER RESEARCH
- The MET Receptor Tyrosine Kinase Is a Potential Novel Therapeutic Target for Head and Neck Squamous Cell Carcinoma
- (2009) T. Y. Seiwert et al. CANCER RESEARCH
- Inhibition of ALK Signaling for Cancer Therapy
- (2009) Y. P. Mosse et al. CLINICAL CANCER RESEARCH
- ALK (Anaplastic Lymphoma Kinase) expression in DRG neurons and its involvement in neuron-Schwann cells interaction
- (2009) Joffrey Degoutin et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Discovery of OSI-906: a selective and orally efficacious dual inhibitor of the IGF-1 receptor and insulin receptor
- (2009) Mark J Mulvihill et al. Future Medicinal Chemistry
- Prognostic significance of c-Met expression in glioblastomas
- (2008) Doo-Sik Kong et al. CANCER
- Initial testing (stage 1) of sunitinib by the pediatric preclinical testing program
- (2008) John M. Maris et al. PEDIATRIC BLOOD & CANCER
- Initial testing (stage 1) of a monoclonal antibody (SCH 717454) against the IGF-1 receptor by the pediatric preclinical testing program
- (2008) E. Anders Kolb et al. PEDIATRIC BLOOD & CANCER
- Initial testing of the VEGFR inhibitor AZD2171 by the pediatric preclinical testing program
- (2007) John M. Maris et al. PEDIATRIC BLOOD & CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started